文章摘要 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Nitrosative stress drives heart failure with preserved ejection fraction
Atherosclerotic plaque with ultrasonic attenuation affects coronary reflow and infarct size in patients with acute coronary syndrome: an intravascular ultrasound study
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions
Cardiovascular effects of radiation therapy

Editorial

2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL：Can J Cardiol.

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett.

11291

Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF